PTC Therapeutics to Host R&D Day

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) will host an R&D Day on Dec. 2, 2025 at 9:30 a.m. EST in New York City, with a live webcast and replay available for ~30 days.

CEO Matthew B. Klein, M.D., and R&D leaders will present updates on the company’s proprietary small molecule splicing and inflammation platforms, including new targets and programs. Investors can register and access the webcast via the Events and Presentations page in the company’s Investor website.

Event to take place on Dec. 2, 2025 in New York City

WARREN, N.J., Nov. 20, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host an R&D Day to discuss its pipeline on Dec. 2, 2025, at 9:30 a.m. EST in New York City. The event will also be webcast.

Matthew B. Klein, M.D., Chief Executive Officer, and PTC research and development team leaders will provide an update on the company's proprietary small molecule splicing and inflammation platforms, including new targets and programs.

To register for the webcast, please visit the Events and Presentations page on the Investors section of the PTC Therapeutics website at http://ir.ptcbio.com/events-presentations. A replay will be available for approximately 30 days following the event.

ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Facebook and Instagram.

For More Information:

Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com 

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-rd-day-302621284.html

SOURCE PTC Therapeutics, Inc.

FAQ

When is PTC Therapeutics' R&D Day 2025 (PTCT) and what time does it start?

PTC Therapeutics' R&D Day is on Dec. 2, 2025 and begins at 9:30 a.m. EST.

How can I watch the PTCT R&D Day webcast on Dec. 2, 2025?

You can register and view the live webcast via the Events and Presentations page on PTC Therapeutics' investor website.

Will there be a replay of the PTCT R&D Day webcast and for how long?

Yes, a replay will be available for approximately 30 days after the event.

Who will present at PTC Therapeutics' R&D Day and what topics will be covered?

CEO Matthew B. Klein, M.D. and R&D leaders will discuss the company's small molecule splicing and inflammation platforms, including new targets and programs.

Where is PTC Therapeutics hosting the R&D Day and is it open to investors?

The event takes place in New York City and is accessible to investors via the webcast registration on the company's investor site.